David M. Blank quoted in article “Expect Steady Audits, Enforcement; Pay Squeeze, Fewer Rules Raise Ante for CCOs”Report on Medicare Compliance 01/08/18
Below is an excerpt:
“There’s no question opioid enforcement will be the primary civil, criminal and administrative enforcement issue of 2018,” says David Blank, former senior counsel at the HHS Office of Inspector General. “Everyone will be under the microscope, from manufacturers to patients.” OIG will target physicians who are prescribing outliers, with Medicare exclusion the most likely remedy, says Blank, with Quarles & Brady LLP in Washington, D.C. For hospitals, the main concern is the way their physicians prescribe. As time marches on, Blank says hospitals will need improved internal controls over opioid purchases, and their pharmacies should monitor dispensing (e.g., standing orders in post-labor and delivery).
Originally published in Report on Medicare Compliance, a publication of the Health Care Compliance Association, January 8, 2018